letrozole has been researched along with Cancer of Pelvis in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Letrozole was then given at a daily dose of 2." | 5.31 | Endometrial stromal sarcoma: objective response to letrozole. ( Aghajanian, C; Maluf, FC; Sabbatini, P; Schwartz, L; Xia, J, 2001) |
| " The long-term use of aromatase inhibitor therapy is thought to be effective and safe for patients with recurrence after BSO." | 1.46 | Long-term efficacy and safety of aromatase inhibitor use for leiomyomatosis peritonealis disseminata. ( Ando, H; Kusunoki, S; Matsuoka, S; Ogishima, D; Ota, T; Sugimori, Y, 2017) |
| "Letrozole was then given at a daily dose of 2." | 1.31 | Endometrial stromal sarcoma: objective response to letrozole. ( Aghajanian, C; Maluf, FC; Sabbatini, P; Schwartz, L; Xia, J, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, H | 1 |
| Kusunoki, S | 1 |
| Ota, T | 1 |
| Sugimori, Y | 1 |
| Matsuoka, S | 1 |
| Ogishima, D | 1 |
| Pink, D | 1 |
| Lindner, T | 1 |
| Mrozek, A | 1 |
| Kretzschmar, A | 1 |
| Thuss-Patience, PC | 1 |
| Dörken, B | 1 |
| Reichardt, P | 1 |
| Maluf, FC | 1 |
| Sabbatini, P | 1 |
| Schwartz, L | 1 |
| Xia, J | 1 |
| Aghajanian, C | 1 |
3 other studies available for letrozole and Cancer of Pelvis
| Article | Year |
|---|---|
Long-term efficacy and safety of aromatase inhibitor use for leiomyomatosis peritonealis disseminata.
Topics: Adult; Aromatase Inhibitors; Female; Humans; Leiomyomatosis; Letrozole; Neoplasm Recurrence, Local; | 2017 |
Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Endometrial Stromal Tumors; Estrogen Replacement Thera | 2006 |
Endometrial stromal sarcoma: objective response to letrozole.
Topics: Abdominal Neoplasms; Antineoplastic Agents; Endometrial Neoplasms; Female; Humans; Letrozole; Liver | 2001 |